Wefen is a leading provider of transfusion and transplantation diagnostic products worldwide. 

Werfen is a global leader in specialized diagnostics, focusing on advancing solutions for Hemostasis, Acute Care Diagnostics, Autoimmunity, Transplantation and Transfusion Medicine. In 2023, Werfen expanded its capabilities by acquiring Immucor, Inc., a renowned provider of advanced diagnostics for blood and organ compatibility. This integration solidified Werfen’s expertise in transfusion and transplant diagnostics, creating a comprehensive platform to support laboratories worldwide.

In transplantation, Werfen offers cutting-edge Human Leukocyte Antigen (HLA) testing technologies, enabling accurate donor-recipient matching and post-transplant monitoring. In transfusion medicine, the company provides innovative solutions for blood typing, cross-matching, and antibody detection to ensure the highest safety and compatibility standards.

Visit Werfen's Transfusion/Transplant Devision